World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
16216
World Ranking
2514
National Ranking
217

Richard Szydlo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard Szydlo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 276 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard Szydlo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Szydlo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Richard Szydlo is affiliated with Imperial College London in the United Kingdom. Their research activity is primarily situated within the field of Medicine, with a focused expertise in Hematology and related subfields including Molecular Biology, Surgery, Genetics, and Immunology.

The main topics of their work encompass chronic myeloid leukemia treatments, hematopoietic stem cell transplantation, COVID-19 clinical research studies, long-term effects of COVID-19, RNA modifications and cancer, mechanical circulatory support devices, and chronic lymphocytic leukemia research.

Frequent publication venues for Szydlo include Blood, British Journal of Haematology, Bone Marrow Transplantation, eJHaem, and Zenodo (CERN European Organization for Nuclear Research).

They have collaborated extensively with several researchers, including Michael Laffan, Deepa J. Arachchillage, Dragana Milojković, Andrew J. Innes, and Aristeidis Chaidos.

Recent papers authored or co-authored by Szydlo include:

  • Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia, 2021, Science Translational Medicine
  • Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients, 2020, Haematologica
  • Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study, 2021, British Journal of Haematology
  • TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia, 2020, British Journal of Haematology
  • Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact, 2021, Immunotherapy Advances

Best Publications

  • Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

    David Marin;Alexandra Bazeos;Francois Xavier Mahon;Lina Eliasson

  • Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis

    Hugues de Lavallade;Jane F. Apperley;Jamshid S. Khorashad;Dragana Milojkovic

  • Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors

    David Marin;Amr R. Ibrahim;Claire Lucas;Gareth Gerrard

  • Results of Allogeneic Bone Marrow Transplants for Leukemia Using Donors Other Than HLA-Identical Siblings

    R Szydlo;J M Goldman;J P Klein;R P Gale

  • Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

    Francesco Dazzi;R. M. Szydlo;C. Craddock;N. C. Cross

  • Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy.

    Amr R Ibrahim;Lina Eliasson;Jane F Apperley;Dragana Milojkovic

  • Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

    Francesco Dazzi;Richard M. Szydlo;Nicholas C P Cross;C. Charles Craddock

  • Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

    Charles Crawley;Marc Lalancette;Richard Szydlo;Maria H Gilleece

  • Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    F van Rhee;R M Szydlo;J Hermans;A Devergie

  • Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

    Eduardo Olavarria;Edward Kanfer;Richard Szydlo;Jaspal Kaeda

  • Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression

    Jamshid S. Khorashad;Hugues de Lavallade;Jane F. Apperley;Dragana Milojkovic

  • Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase

    John M. Goldman;Richard Szydlo;Mary M. Horowitz;Robert Peter Gale

  • The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia

    Mohamad Mohty;Agnes S. M. Yong;Richard M. Szydlo;Jane F. Apperley

  • Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

    Aristeidis Chaidos;Scott Patterson;Richard Szydlo;Mohammed Suhail Chaudhry

  • Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

    Jaspal Kaeda;Derville O'Shea;Derville O'Shea;Richard M. Szydlo;Richard M. Szydlo;Eduardo Olavarria;Eduardo Olavarria

  • Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand

    Francesco Dazzi;Richard M Szydlo;John M Goldman

  • Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

    Dragana Milojkovic;Emma Nicholson;Jane F Apperley;Tessa L Holyoake

  • Three decades of transplantation for chronic myeloid leukemia: what have we learned?

    Jiri Pavlu;Richard M Szydlo;John M Goldman;Jane F Apperley

  • Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response.

    Edward D. Seaton;Richard M. Szydlo;Edward Kanfer;Jane F. Apperley

  • Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis.

    C. Craddock;R. M. Szydlo;Francesco Dazzi;E. Olavarria

  • Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.

    Hugues de Lavallade;Paula Garland;Takuya Sekine;Katja Hoschler

  • Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party.

    A. J. Barrett;F. Locatelli;J. G. Treleaven;A. Gratwohl

Frequent Co-Authors

Jane F. Apperley
Jane F. Apperley Imperial College London
John M. Goldman
John M. Goldman Imperial College London
Francesco Dazzi
Francesco Dazzi King's College London
Irene Roberts
Irene Roberts University of Oxford
Charles Craddock
Charles Craddock Queen Elizabeth Hospital Birmingham
Nigel H. Russell
Nigel H. Russell University of Nottingham
Katayoun Rezvani
Katayoun Rezvani The University of Texas MD Anderson Cancer Center
Nicholas C.P. Cross
Nicholas C.P. Cross University of Southampton
Michael Laffan
Michael Laffan Imperial College London
Steven G.E. Marsh
Steven G.E. Marsh University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare fields like Nurse Practitioner roles offer promising career options. Many students seek the cheapest psychiatric nurse practitioner programs to maximize education affordability while gaining specialized skills in mental health care.

Understanding compensation is important in career planning. The dnp salary transparency resource provides clear data on Doctor of Nursing Practice earnings by state, helping candidates make informed decisions about where to work after graduation.

Professional growth often involves transitions between specialties. For example, transitioning from a Family Nurse Practitioner to an Acute Care NP can be facilitated through a fnp to acute care np bridge program, which offers a tailored curriculum for advancing clinical expertise and expanding career options within immunology-related fields.

For those seeking faster entry into the workforce, accelerated nurse practitioner programs present an efficient pathway to obtain the necessary credentials while balancing other commitments through online study options.

Best Scientists Citing Richard Szydlo

Trending Scientists

Recently Published Articles